|
1
|
Bouma G and Strober W: The immunological
and genetic basis of inflammatory bowel disease. Nat Rev Immunol.
3:521–533. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mokry M, Middendorp S, Wiegerinck CL,
Witte M, Teunissen H, Meddens CA, Cuppen E, Clevers H and
Nieuwenhuis EE: Many inflammatory bowel disease risk loci include
regions that regulate gene expression in immune cells and the
intestinal epithelium. Gastroenterology. 146:1040–1047. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cosnes J, Gower-Rousseau C, Seksik P and
Cortot A: Epidemiology and natural history of inflammatory bowel
diseases. Gastroenterology. 140:1785–1794. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kirsner JB: The historical basis of the
idiopathic inflammatory bowel diseases. Inflammatory Bowel Dis.
1:2–26. 1995. View Article : Google Scholar
|
|
5
|
Pithadia AB and Jain S: Treatment of
inflammatory bowel disease (IBD). Pharmacol Rep. 63:629–642. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rietdijk ST and D'Haens GR: Recent
developments in the treatment of inflammatory bowel disease. J Dig
Dis. 14:282–287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sohrabpour AA, Malekzadeh R and
Keshavarzian A: Current therapeutic approaches in inflammatory
bowel disease. Curr Pharm Des. 16:3668–3683. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van de Merwe JP and Mol GJ: Levels of
Trypsin and alpha-chymotrypsin in feces from patients with Crohn's
disease. Digestion. 24:1–4. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maeda S, Ohno K, Uchida K, Igarashi H,
Goto-Koshino Y, Fujino Y and Tsujimoto H: Intestinal
protease-activated receptor-2 and fecal serine protease activity
are increased in canine inflammatory bowel disease and may
contribute to intestinal cytokine expression. J Vet Med Sci.
76:1119–1127. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Midtvedt T, Zabarovsky E, Norin E, Bark J,
Gizatullin R, Kashuba V, Ljungqvist O, Zabarovska V, Möllby R and
Ernberg I: Increase of faecal tryptic activity relates to changes
in the intestinal microbiome: Analysis of Crohn's disease with a
multidisciplinary platform. PLoS One. 8:e660742013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Safavi F and Rostami A: Role of serine
proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as
a potential therapy for autoimmune diseases. Exp Mol Pathol.
93:428–433. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamasaki K, Di Nardo A, Bardan A, Murakami
M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P,
Hovnanian A, et al: Increased serine protease activity and
cathelicidin promotes skin inflammation in rosacea. Nat Med.
13:975–980. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gran B, Tabibzadeh N, Martin A, Ventura
ES, Ware JH, Zhang GX, Parr JL, Kennedy AR and Rostami AM: The
protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental
autoimmune encephalomyelitis: A potential oral therapy for multiple
sclerosis. Mult Scler. 12:688–697. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lichtenstein GR, Deren JJ, Katz S, Lewis
JD, Kennedy AR and Ware JH: Bowman-Birk inhibitor concentrate: A
novel therapeutic agent for patients with active ulcerative
colitis. Dig Dis Sci. 53:175–180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ware JH, Wan XS, Newberne P and Kennedy
AR: Bowman-Birk inhibitor concentrate reduces colon inflammation in
mice with dextran sulfate sodium-induced ulcerative colitis. Dig
Dis Sci. 44:986–990. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qin XF: Impaired inactivation of digestive
proteases by deconjugated bilirubin: The possible mechanism for
inflammatory bowel disease. Med Hypotheses. 59:159–163. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bermúdez-Humarán LG, Motta JP, Aubry C,
Kharrat P, Rous-Martin L, Sallenave JM, Deraison C, Vergnolle N and
Langella P: Serine protease inhibitors protect better than IL-10
and TGF-β anti-inflammatory cytokines against mouse colitis when
delivered by recombinant lactococci. Microb Cell Fact. 14:262015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stocker R, Yamamoto Y, McDonagh AF, Glazer
AN and Ames BN: Bilirubin is an antioxidant of possible
physiological importance. Science. 235:1043–1046. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou K, Jiang M, Liu Y, Qu Y, Shi G, Yang
X, Qin X and Wang X: Effect of bile pigments on the compromised gut
barrier function in a rat model of bile duct ligation. PLoS One.
9:e989052014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou K, Jiang M, Qin X and Wang X: Role of
bilirubin in digestive proteases inactivation in the lower
intestine. Dig Liver Dis. 47:438–439. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Morris GP, Beck PL, Herridge MS, Depew WT,
Szewczuk MR and Wallace JL: Hapten-induced model of chronic
inflammation and ulceration in the rat colon. Gastroenterology.
96:795–803. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szalai Z, Szász A, Nagy I, Puskás LG,
Kupai K, Király A, Berkó AM, Pósa A, Strifler G, Baráth Z, et al:
Anti-inflammatory effect of recreational exercise in TNBS-induced
colitis in rats: Role of NOS/HO/MPO system. Oxid Med Cell Longev.
2014:9259812014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou K, Jiang M, Qin X and Wang X: Role of
bilirubin in digestive proteases inactivation in the lower
intestine. Dig Liver Dis. 47:438–439. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gilani GS and Sepehr E: Protein
digestibility and quality in products containing antinutritional
factors are adversely affected by old age in rats. J Nutr.
133:220–225. 2003.PubMed/NCBI
|
|
25
|
Camuesco D, Peran L, Comalada M, Nieto A,
Di Stasi LC, Rodriguez-Cabezas ME, Concha A, Zarzuelo A and Galvez
J: Preventative effects of lactulose in the
trinitrobenzenesulphonic acid model of rat colitis. Inflamm Bowel
Dis. 11:265–271. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aube AC, Cherbut C, Barbier M, Xing JH,
Roze C and Galmiche JP: Altered myoelectrical activity in
noninflamed ileum of rats with colitis induced by trinitrobenzene
sulphonic acid. Neurogastroenterol Motil. 11:55–62. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ruyssers NE, de Winter BY, de Man JG,
Loukas A, Pearson MS, Weinstock JV, Van den Bossche RM, Martinet W,
Pelckmans PA and Moreels TG: Therapeutic potential of helminth
soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel
Dis. 15:491–500. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kapitulnik J: Bilirubin: An endogenous
product of heme degradation with both cytotoxic and cytoprotective
properties. Mol Pharmacol. 66:773–779. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maeda S, Maeda S, Ohno K, Kaji N, Hori M,
Fujino Y and Tsujimoto H: Protease-activated receptor-2 induces
proinflammatory cytokine and chemokine gene expression in canine
keratinocytes. Vet Immunol Immunopathol. 153:17–25. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu J, Wang L, Tian XY, Liu L, Wong WT,
Zhang Y, Han QB, Ho HM, Wang N, Wong SL, et al: Unconjugated
bilirubin mediates heme oxygenase-1-induced vascular benefits in
diabetic mice. Diabetes. 64:1564–1575. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Berberat PO, A-Rahim YI, Yamashita K,
Warny MM, Csizmadia E, Robson SC and Bach FH: Heme
oxygenase-1-generated biliverdin ameliorates experimental murine
colitis. Inflamm Bowel Dis. 11:350–359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kawamura K, Ishikawa K, Wada Y, Kimura S,
Matsumoto H, Kohro T, Itabe H, Kodama T and Maruyama Y: Bilirubin
from heme oxygenase-1 attenuates vascular endothelial activation
and dysfunction. Arterioscler Thromb Vasc Biol. 25:155–160.
2005.PubMed/NCBI
|
|
33
|
Lee TS and Chau LY: Heme oxygenase-1
mediates the anti-inflammatory effect of interleukin-10 in mice.
Nat Med. 8:240–246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Varga C, Laszlo F, Fritz P, Cavicchi M,
Lamarque D, Horvath K, Posa A, Berko A and Whittle BJ: Modulation
by heme and zinc protoporphyrin of colonic heme oxygenase-1 and
experimental inflammatory bowel disease in the rat. Eur J
Pharmacol. 561:164–171. 2007. View Article : Google Scholar : PubMed/NCBI
|
